| Autor: |
O'Neil, Margaret J., Archer, Roxanne, Danza, Phoebe, Fisher, Rebecca, Bagwell, Dee Ann, Younis, Ibrahim, Kulkarni, Sonali, Rubin, Zachary, Moon Kim, Balter, Sharon, Terashita, Dawn, Jee Kim, Singhal, Rita, Hancz, Daniel, Gausche-Hill, Marianne, Shah, Naman K. |
| Předmět: |
|
| Zdroj: |
MMWR: Morbidity & Mortality Weekly Report; 6/20/2024, Vol. 73 Issue 24, p546-550, 5p |
| Abstrakt: |
Tecovirimat is the first-line antiviral treatment recommended for severe mpox or for persons with mpox who are at risk for severe disease; tecovirimat is available in the United States under an expanded access investigational new drug (IND) protocol. During the 2022-2023 mpox outbreak, local U.S. health jurisdictions facilitated access to tecovirimat. In June 2022, Los Angeles County (LAC) rapidly developed strategies for tecovirimat distribution using existing medical countermeasure distribution networks established by the Public Health Emergency Preparedness Program and the Hospital Preparedness Program, creating a hub and spoke distribution network consisting of 44 hub facilities serving 456 satellite sites across LAC. IND patient intake forms were analyzed to describe mpox patients treated with tecovirimat. Tecovirimat treatment data were matched with case surveillance data to calculate time from specimen collection to patients receiving tecovirimat. Among 2,281 patients with mpox in LAC, 735 (32%) received tecovirimat during June 2022-January 2023. Among treated patients, approximately two thirds (508; 69%) received treatment through community clinics and pharmacies. The median interval from specimen collection to treatment was 2 days (IQR = 0-5 days). Local data collection and analysis helped to minimize gaps in treatment access and facilitated network performance monitoring. During public health emergencies, medical countermeasures can be rapidly deployed across a large jurisdiction using existing distribution networks, including clinics and pharmacies. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
